s6y
Company name or ticker
Search
CytomX Therapeutics, Inc.
3
Ashworth Alan: Initial statement of insider ownership
Filed
Thursday, October 7, 2021
Period
Sep 29, 2021
Accession number
0001567619-21-018044
Documents
Initial statement of insider ownership
3
Certifications, consents and other formalities
1
Power of Attorney
24.1
Power of Attorney
EX-24.1
On sec.gov
Filing index
All files
Complete submission text
SGML header